期刊文献+

卵巢上皮性癌组织中P27^(kipl)蛋白的表达及临床意义 被引量:2

Expression of P27kipl in ovarian epithelial cancer and its clinical significance
下载PDF
导出
摘要 【目的】探讨卵巢上皮性恶性肿瘤组织中P27kipl蛋白的表达及其临床意义。【方法】采用免疫组化染色(SP)法,检测47例卵巢上皮性恶性肿瘤组织、17例卵巢良性肿瘤组织及10例正常卵巢组织中P27kipl蛋白的表达。【结果】(1)卵巢上皮性恶性肿瘤组织中P27kipl蛋白表达的阳性率,明显低于卵巢良性肿瘤组织及正常卵巢组织(P<0.05)。(2)卵巢上皮性恶性肿瘤组织中,P27kipl蛋白表达的水平与患者的临床分期及病理学分级相关。(3)卵巢上皮性癌患者中,P27kipl蛋白表达阳性者患者的预后较好。【结论】P27kipl蛋白的表达可能在卵巢癌的发生、发展中起重要作用。P27kipl蛋白表达水平的检测有可能作为判断卵巢癌患者预后的有用指标。 [ Objective] To study the expression of P27^kip1 protein in ovarian epithelial cancer and its clinical significance. [Methods] The expression of P27^kip1 protein was examined in 47 cases of ovarian epithelial cancer by immunohistochemistry (sp), and analyze the relationship between the expression and prognosis of the patient. [Results] (1) The expression rates of P27^kip1 protein in malignant tumors was lower than that of benign tumors and normal ovarian tissues. (2) The expression of P27^kip1 protein in ovarian epithelial cancer was correlated with chnical stage and pathological grade. (3) In ovarian epithelial cancer, the positive expressions of P27^kip1 protein may indicate a fair prognosis. [ Conclusions] The results suggest that expression of P27^kip1 protein plays an important role in the incidence and development of ovarian epithelial cancer. The expression of P27^kip1 protein may serve as an independent prognostic factor in assessing the prognosis of ovarian epithelial cancer
出处 《武警医学院学报》 CAS 2009年第2期109-111,共3页 Acta Academiae Medicinae CPAPF
关键词 P27KIPL 卵巢肿瘤 免疫组化染色 预后 P27^kip1 Ovarianneoplasm Immunohistochemistry Prognosis
  • 相关文献

参考文献7

  • 1Polyak K, Lee MH, Erdjument B H. Cloning of P27^kip1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals [J]. Cell, 1994, 78.- 59-67.
  • 2Pietepol JA, Bohlander SK, Sato Y. Assignment of the human P27^kip1 gene to 12^13 and its analysis in leukemias [J]. Cancer Res, 1995, 55: 1206- 1210.
  • 3Valeria M, Alessandrc S, Carman P, et al . Frequent loss of expression of the cyclin dependent kinase inhibitor P27 in epithelial ovarian cancer [J]. Cancer Res, 1999, 59: 3790-3794.
  • 4Malander S, Ridderheim M, Masback A, et al . One in 10 ovarian cancer patient canT germ line BRCAI or BRCA2 mutations: results of a prospeetive study in Southern Sweden [ J ]. Eur J Cancer, 2004, 40 (3) : 422 - 428.
  • 5Hashiguchi Y, Tsuda H, Inoue T, et al . Aheration of cell cycle regulators correlate with survival in epithelial ovarian cancer patients [ J ]. Hum Pathol, 2004, 35 (2): 165-175.
  • 6Shigemasa K, Shiroyama Y, Sawasaki T, et al . Underexpression of cyclin-dependent kinase inhibitor P27 is associated with poor prognosis in serous ovarian carcinomas [J]. Int J Oncol, 2001, 18 (5): 953 - 958.
  • 7Sui L, Dong Y, Watanabe Y, et al . Clinical significance of skp2 expression, alone and combined with Jabl and p27 in epithelial ovarian tumors [J]. Oncol Rep, 2006, 15 (4): 765-771.

同被引文献23

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部